Omega Healthcare Investors, Inc. cash flow to debt ratio of 20.64% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Omega Healthcare Investors, Inc.'s free cash flow has increased 23.27% from $712.69M last year to $878.55M, signaling increasing performance

Omega Healthcare Investors, Inc.'s debt to equity ratio is 0.75, which means that the company's assets are unhealthy financed, signaling financial risk.

Omega Healthcare Investors, Inc.'s debt has decreased relative to shareholder equity from 1.07 last year to 0.75 today, signaling strengthened financials

Omega Healthcare Investors, Inc. has a net debt to EBITDA ratio of 3.61x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Omega Healthcare Investors, Inc.'s interest coverage ratio of 3.88 indicates that earnings with good margin can cover interest payments on company debt

Omega Healthcare Investors, Inc.'s profit margin has increased (71.90%) in the last year from 38.65% to 66.43%, signaling increasing performance

Omega Healthcare Investors, Inc.'s short-term assets of $2.06B exceed its short-term liabilities of $594.55M

Omega Healthcare Investors, Inc.'s return on assets of 8.55% is higher than the 5.00% threshold, indicating efficient asset utilization

Omega Healthcare Investors, Inc.'s return on equity of 16.51%, is higher than 15.00%, indicating good performance

Omega Healthcare Investors, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Omega Healthcare Investors, Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Omega Healthcare Investors, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Omega Healthcare Investors, Inc. has a free cash flow yield of 6.20%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Omega Healthcare Investors, Inc.'s yearly earnings has increased 45.23% since last year from $406.33M to $590.11M, signaling increasing performance

Omega Healthcare Investors, Inc.'s yearly revenue has increased 13.19% since last year from $1.05B to $1.19B, signaling increasing performance

ROIC 34.60% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Omega Healthcare Investors, Inc.'s 3-year revenue CAGR of 10.91% is positive, indicating growing revenue over the past 3 years

Omega Healthcare Investors, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Omega Healthcare Investors, Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Omega Healthcare Investors, Inc. is overvalued relative to its fair value price of 31.95 based on Discounted Cash Flow model

Omega Healthcare Investors, Inc. has an earnings yield of 6.06%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Omega Healthcare Investors, Inc. is overvalued relative to its fair value price of 13.41 based on EBITDA multiple model

Omega Healthcare Investors, Inc. has an EV/EBITDA ratio of 15.73x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Omega Healthcare Investors, Inc. is overvalued relative to its fair value price of 41.85 based on Earnings Fair Value model

Omega Healthcare Investors, Inc. has a PEG-ratio under 1 which is considered undervalued

Omega Healthcare Investors, Inc. has a price-to-book ratio of 2.50x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Omega Healthcare Investors, Inc. has a price-to-sales ratio of 10.96x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue